6 January 2010

Professor Roland Wolf OBE

Professor Roland Wolf, director of the Biomedical Research Institute at the University of Dundee, has been rewarded for his services to science with an OBE in the New Year’s Honours list.

Professor Wolf is internationally renowned for his work in the field of molecular pharmacology, specifically drug resistance in cancer patients. He said he was delighted to be awarded such a prestigious honour.

'I feel very privileged to have received an OBE in the New Year Honours List,' he said. 'I would very much like to say that honours such as this reflect the combined contributions of many individuals who have worked with me over the years.'

After working in West Germany, the US and England, he headed the Imperial Cancer Research Fund's Medical Oncology Unit at the Western General Hospital in Edinburgh.

In 1992, Professor Wolf relocated his molecular pharmacology group to Dundee, and in 1998 his discovery of the role played by a single gene in protection against cancer made international headlines.

He was awarded the Scottish Enterprise Life Sciences Award in 2006 for his leading contribution to life sciences in Scotland, co-founded the specialist drug company CXR Biosciences, and is Honorary Director of Cancer Research UK’s Molecular Pharmacology Unit.

For media enquiries contact:
Grant Hill
Press Officer
University of Dundee
Nethergate, Dundee, DD1 4HN
TEL: 01382 384768
E-MAIL: g.hill@dundee.ac.uk
MOBILE: 07854 953277